Clients from investors to startups to the world’s largest healthcare companies turn to us on a full range of transactions and other legal matters.
Companies appreciate our depth of experience in areas including pharmaceuticals, biotechnology, and diagnostic and medical devices. Over the past 10 years, we have completed approximately 575 capital markets transactions in healthcare, totaling over $470 billion. Over the same time frame, we advised on more than 175 M&A transactions, with a cumulative deal value of approximately $1.1 trillion and a market share of over 25%, according to data from Refinitiv.
Healthcare and life sciences clients trust in our understanding of the complex issues they face in acquisitions, divestitures, joint ventures, partnerships, strategic alliances, licensing arrangements, collaborations, distribution agreements, internal investigations and litigation.
Many transactions and other matters have an intellectual property component. Clients appreciate that our team includes lawyers with strong biomedical backgrounds such as Ph.D.s and biomedical engineering degrees.